Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Published Date: 18 Feb 2023

Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies

2.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

3.

Many women undergo annual mammography, despite biennial screening recommendations

4.

High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment

5.

Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot